Valuation Novo Nordisk A/S

Stocks

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 09/06/2026 BST			5-day change	1st Jan Change
269.50 ^DKK	-0.92%		-5.41%	-17.14%

11:57am	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
10:20am	NOVO NORDISK : Deutsche Bank reiterates its Neutral rating	ZD

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,674,992	2,118,803	3,112,331	2,772,285	1,445,242	1,194,653	-	-
Change	-	26.5%	46.89%	-10.93%	-47.87%	-17.34%	-	-
Enterprise Value (EV) ¹	1,684,152	2,121,013	3,109,107	2,848,764	1,549,238	1,312,288	1,308,935	1,294,451
Change	-	25.94%	46.59%	-8.37%	-45.62%	-15.29%	-0.26%	-1.11%
P/E ratio	35.4x	38.4x	37.5x	27.6x	14.1x	11.9x	12.7x	11.6x
PBR	24x	25.6x	29.4x	19.3x	-	5.22x	4.68x	4.17x
PEG	-	2.2x	0.7x	1.3x	7.98x	-6.4x	-1.98x	1.22x
Capitalization / Revenue	11.9x	12x	13.4x	9.55x	4.68x	4.09x	4x	3.74x
EV / Revenue	12x	12x	13.4x	9.81x	5.01x	4.49x	4.38x	4.05x
EV / EBITDA	26x	25.8x	27.8x	19.3x	10.4x	9.18x	9.25x	8.51x
EV / EBIT	28.7x	28.4x	30.3x	22.2x	12.1x	10.8x	10.9x	10x
EV / FCF	57.4x	37x	45.5x	38.6x	26.3x	26x	17.7x	16.2x
FCF Yield	1.74%	2.7%	2.2%	2.59%	3.81%	3.85%	5.63%	6.16%
Dividend per Share ²	5.2	6.2	9.4	11.4	11.7	11.35	10.9	11.89
Rate of return	1.41%	1.32%	1.35%	1.83%	3.6%	4.21%	4.05%	4.41%
EPS ²	10.37	12.22	18.62	22.63	23.03	22.6	21.15	23.17
Distribution rate	50.1%	50.7%	50.5%	50.4%	50.8%	50.2%	51.5%	51.3%
Net sales ¹	140,800	176,954	232,261	290,403	309,064	292,395	298,891	319,244
EBITDA ¹	64,669	82,171	111,987	147,446	149,640	142,977	141,514	152,191
EBIT ¹	58,644	74,809	102,574	128,339	127,658	121,752	119,875	129,297
Net income ¹	47,757	55,525	83,683	100,988	102,434	98,693	93,986	101,497
Net Debt ¹	9,160	2,210	-3,224	76,479	103,996	117,635	114,282	99,798
Reference price ²	367.50	469.00	698.10	624.20	325.25	269.50	269.50	269.50
Nbr of stocks (in thousands)	4,557,801	4,517,704	4,458,288	4,441,340	4,443,479	4,432,851	-	-
Announcement Date	02/02/22	01/02/23	31/01/24	05/02/25	03/02/26	-	-	-

¹DKK in Million²DKK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NOVO NORDISK A/S	12.03x	4.53x	9.26x	4.17%	186B
ELI LILLY AND COMPANY	33.62x	12.22x	25.16x	0.59%	1,025B
JOHNSON & JOHNSON	24.81x	5.72x	15.56x	2.3%	559B
ABBVIE INC.	27.31x	6.66x	13.61x	3.08%	394B
ROCHE HOLDING AG	17.31x	4.28x	10.51x	3.11%	324B
MERCK & CO., INC.	53.32x	4.96x	20.16x	2.8%	295B
ASTRAZENECA PLC	23.32x	4.83x	13.75x	1.81%	286B
NOVARTIS AG	20.51x	5.3x	12.89x	3.08%	270B
AMGEN INC.	22.48x	6.03x	10.53x	2.92%	187B
GILEAD SCIENCES, INC.	-45.84x	5.54x	31.24x	2.53%	159B
Average	18.89x	6.01x	16.27x	2.64%	368.53B
Weighted average by Cap.	24.91x	7.29x	17.71x	2.17%